Malden Transportation, Inc. et al. v. Uber Technologies, Inc. et al. (16-cv-12538).

In a series of consolidated cases (discussed further here and here), a large number of Boston-area cab companies accuse Uber, as well as Uber founders Travis Kalanick and Garrett Camp, of unfair competition in violation of Massachusetts state and common law, and some of the plaintiffs further allege that Uber violated state and federal antitrust … Continue reading “Malden Transportation, Inc. et al. v. Uber Technologies, Inc. et al. (16-cv-12538).”

Malden Transportation, Inc. et al. v. Uber Technologies, Inc. et al. (16-cv-12538).

Judge Gorton consolidated seven different antitrust actions against Uber for pretrial purposes. Each complaint asserted substantially similar claims and operative facts and involved the same defendants.  The main difference in the lawsuits related to alleged violations of local transportation ordinances, and the different cases generally grouped cab companies from individual cities or towns together – I … Continue reading “Malden Transportation, Inc. et al. v. Uber Technologies, Inc. et al. (16-cv-12538).”

Dot Ave Cab, Inc. et al. v. Uber Technologies, Inc. (17-cv-10180).

A large number of Boston cab companies filed a second amended complaint against Uber, adding ten new companies as plaintiffs to bring the total number of plaintiffs to one hundred and ninety-six.  The cab companies allege that Uber controls 80% of the ride-hail market, which is defined as the “low-cost, on-demand, Ride Hail ground transportation … Continue reading “Dot Ave Cab, Inc. et al. v. Uber Technologies, Inc. (17-cv-10180).”

Oxford Immunotec Ltd. v. Qiagen, Inc. et al. (15-13124).

Judge Gorton denied Oxford’s motion for a preliminary injunction on sales of Qiagen’s QFT-Plus one-tube option for the diagnosis of tuberculosis. According to the opinion, tuberculosis is detected in two ways – through skin tests or through in vitro blood test known as interferon gamma release assay (“IGRA”).  Currently, Oxford and Qiagen offer the only … Continue reading “Oxford Immunotec Ltd. v. Qiagen, Inc. et al. (15-13124).”